Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2012
05/09/2012CN101926904B Medicinal liquor for treating rheumatic arthralgia and osteoarthrosis
05/09/2012CN101843769B Medicament for treating systemic sclerosis and preparation method thereof
05/09/2012CN101745079B Transdermal patch with functions of expelling wind and removing dampness and reducing swelling and easing pain and preparation method thereof
05/09/2012CN101700360B Chinese medicine prescription for curing bi syndrome
05/09/2012CN101693688B Indeno isoquinolone derivatives, preparation process and medical application thereof
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/09/2012CN101628921B Preparation method of plant source D-glucosamine hydrochloride
05/09/2012CN101574448B Traditional Chinese medicine combination suitable for curing hyperosteogeny by external administration and preparation method thereof
05/09/2012CN101530527B Chinese medicament for treating intervertebral disc
05/09/2012CN101518643B 消炎、止痛膏药 Anti-inflammatory, analgesic plaster
05/09/2012CN101511796B Imidazole derivative
05/09/2012CN101439069B Leaf extract of Herba siegesbeckiae, preparation method and uses thereof
05/09/2012CN101199677B Chinese medicine agent for treating injuries from falls, rheumatoid arthritis and preparing method thereof
05/09/2012CN101199613B Chinese medicine compound for treating lumbar hyperosteogeny
05/09/2012CN101133037B 6-membered heterocyclic compound and use thereof
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173689 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012CA2631841C Fast-acting oral peptide pharmaceutical products
05/08/2012CA2589095C Protein formulation for administering an active enamel substance
05/08/2012CA2532565C Use of calcitonin in osteoarthritis
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/03/2012WO2012058254A1 Benzimidazole inhibitors of leukotriene production
05/03/2012WO2012057417A1 Composition containing okamejei kenojei extract
05/03/2012WO2012057068A1 23-yne-vitamin d3 derivative
05/03/2012WO2012056478A1 Oxazole and isoxazole crac modulators
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012056044A1 Treatment for dupuytren's disease
05/03/2012WO2012054996A1 Functionalized aryl and/or heteroaryl urea compounds; a method for synthesizing same; a pharmaceutical composition containing such compounds and uses thereof
05/03/2012WO2011159124A3 Novel benzoxazole derivative having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing same
05/03/2012WO2011155728A3 Composition for preventing or treating osteoporosis, and manufacturing method therefor
05/03/2012WO2011120013A3 Vista regulatory t cell mediator protein, vista binding agents and use thereof
05/03/2012US20120108668 Metabolic profiles
05/03/2012US20120108629 New use of neferine
05/03/2012US20120108627 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108616 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
05/03/2012US20120108614 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108613 Compounds and compositions for treating chemical warfare agent-induced injuries
05/03/2012US20120108610 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108595 Platelet-activating factor receptor antagonists
05/03/2012US20120108594 PROCESS FOR PREPARING SALTS OF 4-[[5-[(CYCLOPROPYLAMINO)CARBONYL]-2-METHYLPHENYL]AMINO]-5-METHYL-N-PROPYLPYRROLO[2,1-f][1,2,4]TRIAZINE-6-CARBOXAMIDE AND NOVEL STABLE FORMS PRODUCED THEREIN
05/03/2012US20120108587 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108571 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
05/03/2012US20120108566 Nicotinamides as jak kinase modulators
05/03/2012US20120108565 Pyrrole carboxylic acid derivatives as antibacterial agents
05/03/2012US20120108559 Receptor activator of the rank receptor complex inhibitor
05/03/2012US20120108536 Pharmaceutical composition and method for inhibiting inflammation
05/03/2012US20120108516 The use of midkine protein and the protein-containing medical device
05/03/2012US20120108515 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
05/03/2012US20120108507 Methods for In Vivo Cell Reprogramming
05/03/2012US20120108496 Short-chain peptides as parathyroid hormone (pth) receptor agonist
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107846 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
05/03/2012US20120107421 Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture
05/03/2012US20120107407 Bone graft and biocomposite for prosthetic dentistry
05/03/2012US20120107401 Osteoconductive matrices comprising statins and methods of using the same
05/03/2012US20120107383 Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
05/03/2012US20120107373 Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use
05/03/2012US20120107330 Antagonists, uses & methods for partially inhibiting tnfr1
05/03/2012US20120107313 Mammalian receptor proteins; related reagents and methods
05/03/2012US20120107298 Use of LCAT for Treating Anemia and Red Blood Cell Dysfunction
05/03/2012US20120107281 Compositions and methods for modifying cell surface glycans
05/03/2012US20120107269 Thiophene derivatives
05/03/2012DE102010043318A1 Calciumcarbonat enthaltende Zusammensetzung Calcium carbonate-containing composition
05/03/2012CA2847197A1 Treatment for dupuytren's disease
05/03/2012CA2815501A1 23-yne-vitamin d3 derivative
05/03/2012CA2814768A1 Oxazoline and isoxazoline derivatives as crac modulators
05/02/2012EP2447374A2 In vitro method for the prognosis or prediction of the response in patients with rheumatoid arthritis treated with agents that recognize the cd20 membrane receptor in b lymphocytes
05/02/2012EP2447266A1 Pyrimidopyridine compound used as a CSBP/RK/p38 modulator
05/02/2012EP2446889A1 Difructose anhydride-containing composition for use in improving bowel movement
05/02/2012EP2446884A1 Composition for inhibiting inflammation comprising hyaluronic acid and a hmg-coa reductase inhibitor
05/02/2012EP2445911A1 5-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
05/02/2012EP2445900A2 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
05/02/2012EP2445512A2 Enhancement of bmp retention
05/02/2012EP2445510A1 Compositions for treating degenerative joint diseases
05/02/2012EP2445499A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1664315B1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012CN102439021A Novel galactoside inhibitors of galectins
05/02/2012CN102432694A Medicine for promoting bone cell growth
05/02/2012CN102432620A Resveratrol tetramer compound, its preparation method and application
05/02/2012CN102432599A Crystal form of oxalate of dipeptidyl peptidase inhibitor and preparation method and application thereof
05/02/2012CN102432585A Crystal forms of 1,3,6,7-tetramethoxyxanthone and pharmaceutical composition, preparation method and application thereof
05/02/2012CN102430129A Bone morphogenetic protein-2/basic fibroblast growth factor (BMP-2/bFGF) double-gene chitosan nano-microcapsules and application thereof
05/02/2012CN102430117A Modified proteases that inhibit complement activation
05/02/2012CN102430090A Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 820